Apogee Therapeutics, Inc.APGENASDAQ

Revenue (LTM)

Net Income (LTM)

$-256M

-40.5% YoY

Free Cash Flow

$-233M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.2B)

Unprofitable

Metric	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	0	0	0	0
Gross Profit	0	0	0	-1
Operating Income	-31	-93↓202.7%	-217↓133.2%	-286↓31.7%
Net Income	-40	-84↓111.1%	-182↓116.9%	-256↓40.5%
EBITDA	-40	-75↓88.4%	-217↓189.0%	-284↓31.1%
EPS Diluted	-0.79	-1.66↓110.1%	-3.30↓98.8%	-4.22↓27.9%

Metric	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	152	118↓22.1%	142↑19.8%	132↓7.2%
Total Current Assets	152	398↑162.0%	530↑33.0%	741↑40.0%
Total Assets	152	401↑164.0%	754↑87.8%	937↑24.3%
Total Current Liabilities	10	21↑106.0%	29↑38.9%	28↓2.3%
Total Liabilities	10	21↑115.3%	37↑72.9%	33↓10.5%
Total Equity	142	380↑167.4%	717↑88.7%	904↑26.1%
Total Debt	0	2	12↑481.7%	9↓25.2%
Net Debt	-152	-116↑23.4%	-130↓11.8%	-123↑5.6%

Metric	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-16	-75↓355.1%	-171↓129.0%	-227↓32.9%
Capital Expenditure	0	-0	-1↓589.8%	-5↓346.8%
Free Cash Flow	-16	-75↓356.1%	-172↓130.0%	-233↓35.0%
Stock-Based Comp	2	6↑184.9%	23↑282.3%	46↑98.3%
Net Change in Cash	152	-33↓121.9%	23↑170.5%	-11↓144.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance